Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)
05/06/2024
/
Publications
/
Clinical Trial
Patients (n=440) were randomized to undergo IMRT(n=219) or IMPT (n=221) at 21 institutions. The median age was 61 years and HPV/p16 was positive in 95%. IC was...
An Interview with Dr. Steven Frank
17/07/2024
/
Webinar
/
Clinical Trial
Learn from Dr. Steven Frank as he discusses the results, challenges, and implications of the study "Phase III randomized trial of intensity-modulated proton...
Case Study: Head & Neck
23/07/2024
/
Webinar
Case study on Head & Neck by Dr. Brandon Gunn at ISOP 2024.
Proton beam irradiation with anti-VEGF therapy for polypoidal choroidal vasculopathy: results of a 24-month, phase II randomized study.
25/02/2025
/
Publications
This randomized study from the Fudan group, China, randomized patients with polypoidal choroidal vasculopathy (PCV)/ aneurysmal type 1 macular...
PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy.
25/02/2025
/
Publications
Published in the Red Journal, this guideline document from PTCOG Ocular Group summarized the current state of proton ocular treatment with available clinical...
Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
03/04/2019
/
Publications
This study compared differential effects of enucleation and PBR on 115 uveal melanoma patients based on the patient-reported outcomes. This study found that PBR...
PBRT for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases.
13/07/2022
/
Publications
A study looked at the characteristics of patients with uveal melanoma treated in the proton center in the UK. A total of 1084 patients with uveal melanoma were...
30 years of ocular PT, the Nice view.
13/07/2022
/
Publications
/
Dosimetry
Pencil Beam Scanning - PBS
PT101
An article by the NICE group presented their 30 years experiences in treating ocular tumors with proton therapy. This article highlighted the fact that 6684...
Proton Therapy Patient Selection/Triage at Corewell Health and the future of proton therapy with ARC
09/11/2022
/
Webinar
/
Proton therapy center
Ramp-up
ARC therapy
In this presentation, held during ASTRO 2022, Dr. Craig Stevens offers an overview of the proton therapy activity at Corewell Health – formerly Beaumont Health...
Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam therapy in uveal melanoma.
29/04/2024
/
Publications
/
Pencil Beam Scanning - PBS
Published in the Green Journal, this study compared two cohorts of each 153 patients with uveal melanoma treated with fractionated stereotactic photon-RT (50 Gy...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.